- Home
- MYNZ vs PRSO Comparison
MYNZ vs PRSO Comparison
Compare MYNZ & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYNZ
- PRSO
- Stock Information
- Founded
- MYNZ 2021
- PRSO 2008
- Country
- MYNZ Germany
- PRSO United States
- Employees
- MYNZ N/A
- PRSO N/A
- Industry
- MYNZ Biotechnology: Pharmaceutical Preparations
- PRSO Semiconductors
- Sector
- MYNZ Health Care
- PRSO Technology
- Exchange
- MYNZ Nasdaq
- PRSO Nasdaq
- Market Cap
- MYNZ 7.6M
- PRSO 5.1M
- IPO Year
- MYNZ 2021
- PRSO 2001
- Fundamental
- Price
- MYNZ $1.90
- PRSO $0.90
- Analyst Decision
- MYNZ Buy
- PRSO Strong Buy
- Analyst Count
- MYNZ 2
- PRSO 1
- Target Price
- MYNZ $14.00
- PRSO $3.00
- AVG Volume (30 Days)
- MYNZ 186.6K
- PRSO 238.9K
- Earning Date
- MYNZ 08-05-2025
- PRSO 08-11-2025
- Dividend Yield
- MYNZ N/A
- PRSO N/A
- EPS Growth
- MYNZ N/A
- PRSO N/A
- EPS
- MYNZ N/A
- PRSO N/A
- Revenue
- MYNZ $893,991.00
- PRSO $15,626,000.00
- Revenue This Year
- MYNZ $26.06
- PRSO $0.69
- Revenue Next Year
- MYNZ $4.97
- PRSO $35.21
- P/E Ratio
- MYNZ N/A
- PRSO N/A
- Revenue Growth
- MYNZ N/A
- PRSO 35.50
- 52 Week Low
- MYNZ $1.34
- PRSO $0.52
- 52 Week High
- MYNZ $19.00
- PRSO $2.34
- Technical
- Relative Strength Index (RSI)
- MYNZ 49.46
- PRSO 37.33
- Support Level
- MYNZ $1.89
- PRSO $0.89
- Resistance Level
- MYNZ $2.07
- PRSO $1.04
- Average True Range (ATR)
- MYNZ 0.21
- PRSO 0.06
- MACD
- MYNZ 0.02
- PRSO -0.02
- Stochastic Oscillator
- MYNZ 38.10
- PRSO 1.60
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.